Šárka Dvořáková

1.5k total citations
21 papers, 527 citations indexed

About

Šárka Dvořáková is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Šárka Dvořáková has authored 21 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 7 papers in Oncology. Recurrent topics in Šárka Dvořáková's work include Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer-related Molecular Pathways (6 papers) and Congenital gastrointestinal and neural anomalies (5 papers). Šárka Dvořáková is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer-related Molecular Pathways (6 papers) and Congenital gastrointestinal and neural anomalies (5 papers). Šárka Dvořáková collaborates with scholars based in Czechia, Netherlands and Poland. Šárka Dvořáková's co-authors include Eliška Václavíková, Běla Bendlová, Petr Vlček, Vlasta Sýkorová, Daniela Kodetová, Josef Včelák, Aleš Ryška, Rami Katra, Jaromı́r Astl and J Dušková and has published in prestigious journals such as PLoS ONE, Human Pathology and Molecular and Cellular Endocrinology.

In The Last Decade

Šárka Dvořáková

21 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Šárka Dvořáková Czechia 12 389 176 141 127 119 21 527
Eliška Václavíková Czechia 14 492 1.3× 200 1.1× 161 1.1× 152 1.2× 143 1.2× 33 653
Vlasta Sýkorová Czechia 12 386 1.0× 129 0.7× 143 1.0× 129 1.0× 109 0.9× 18 501
Agnieszka Walczyk Poland 13 390 1.0× 97 0.6× 123 0.9× 151 1.2× 126 1.1× 34 510
Zbigniew Wygoda Poland 11 344 0.9× 183 1.0× 60 0.4× 82 0.6× 111 0.9× 29 512
Claire Coire Canada 13 216 0.6× 140 0.8× 72 0.5× 54 0.4× 58 0.5× 18 415
Margarida M. Moura Portugal 10 462 1.2× 59 0.3× 215 1.5× 171 1.3× 165 1.4× 17 593
Naisi Huang China 15 154 0.4× 187 1.1× 112 0.8× 52 0.4× 192 1.6× 34 539
Ana Clode Portugal 10 146 0.4× 68 0.4× 145 1.0× 95 0.7× 93 0.8× 15 330
Fernando Rodrigues Portugal 11 279 0.7× 143 0.8× 90 0.6× 72 0.6× 112 0.9× 41 437
Alyaksandr V. Nikitski United States 14 369 0.9× 71 0.4× 100 0.7× 140 1.1× 93 0.8× 22 456

Countries citing papers authored by Šárka Dvořáková

Since Specialization
Citations

This map shows the geographic impact of Šárka Dvořáková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šárka Dvořáková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šárka Dvořáková more than expected).

Fields of papers citing papers by Šárka Dvořáková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šárka Dvořáková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šárka Dvořáková. The network helps show where Šárka Dvořáková may publish in the future.

Co-authorship network of co-authors of Šárka Dvořáková

This figure shows the co-authorship network connecting the top 25 collaborators of Šárka Dvořáková. A scholar is included among the top collaborators of Šárka Dvořáková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šárka Dvořáková. Šárka Dvořáková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sýkorová, Vlasta, Šárka Dvořáková, Eliška Václavíková, et al.. (2020). RET , NTRK , ALK , BRAF , and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid. 30(12). 1771–1780. 104 indexed citations
2.
Hálková, Tereza, Šárka Dvořáková, Vlasta Sýkorová, et al.. (2016). Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma. Cancer Biomarkers. 17(1). 97–106. 11 indexed citations
3.
Hálková, Tereza, Šárka Dvořáková, Eliška Václavíková, et al.. (2015). A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history. Human Pathology. 46(12). 1962–1969. 7 indexed citations
4.
Václavíková, Eliška, Šárka Dvořáková, Vlasta Sýkorová, et al.. (2015). Search for new candidate genes in RET mutation-negative families with hereditary medullary thyroid carcinoma using next generation sequencing. Endocrine Abstracts. 2 indexed citations
5.
Sýkorová, Vlasta, Šárka Dvořáková, Josef Včelák, et al.. (2015). Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.. PubMed. 35(4). 2029–36. 47 indexed citations
6.
Dvořáková, Šárka, Vlasta Sýkorová, Eliška Václavíková, et al.. (2015). A 3-bp Deletion VK600-1E in the BRAF Gene Detected in a Young Woman with Papillary Thyroid Carcinoma. Endocrine Pathology. 26(4). 309–314. 1 indexed citations
7.
Václavíková, Eliška, et al.. (2014). RET Variants and Haplotype Analysis in a Cohort of Czech Patients with Hirschsprung Disease. PLoS ONE. 9(6). e98957–e98957. 5 indexed citations
8.
Laco, Ján, Kateřina Kamarádová, Šárka Dvořáková, et al.. (2012). Cribriform adenocarcinoma of minor salivary glands may express galectin-3, cytokeratin 19, and HBME-1 and contains polymorphisms of RET and H-RAS proto-oncogenes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(5). 531–540. 30 indexed citations
9.
Václavíková, Eliška, et al.. (2011). Hirschsprung’s disease and medullary thyroid carcinoma: 15-year experience with molecular genetic screening of the RET proto-oncogene. Pediatric Surgery International. 28(2). 123–128. 10 indexed citations
10.
Sýkorová, Vlasta, Šárka Dvořáková, Aleš Ryška, et al.. (2010). BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic. Journal of Endocrinological Investigation. 33(5). 318–324. 31 indexed citations
11.
Václavíková, Eliška, Šárka Dvořáková, Vlasta Sýkorová, et al.. (2009). RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. Endocrine. 36(3). 419–424. 22 indexed citations
12.
Frank‐Raue, Karin, Nelson Wohllk, Ana Luiza Maia, et al.. (2008). Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Endocrine Related Cancer. 15(4). 1035–1041. 38 indexed citations
13.
Dvořáková, Šárka, Eliška Václavíková, Vlasta Sýkorová, et al.. (2008). Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas. Molecular and Cellular Endocrinology. 284(1-2). 21–27. 87 indexed citations
14.
Ryška, Aleš, et al.. (2008). Paraganglioma‐like medullary thyroid carcinoma: fine needle aspiration cytology features with histological correlation. Cytopathology. 20(3). 188–194. 15 indexed citations
15.
Maruna, P, J Dušková, Z Límanová, et al.. (2008). Mixed medullary and follicular cell carcinoma of the thyroid in a 71-year-old man with history of malignant melanoma.. PubMed. 14(4). CS31–6. 6 indexed citations
16.
Dvořáková, Šárka, Eliška Václavíková, Aleš Ryška, et al.. (2006). Double Germline Mutations in the RET Proto-oncogene in MEN 2A and MEN 2B Kindreds. Experimental and Clinical Endocrinology & Diabetes. 114(4). 192–196. 11 indexed citations
17.
Dvořáková, Šárka, et al.. (2006). The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease. Pediatric Surgery International. 22(12). 991–995. 10 indexed citations
18.
Dvořáková, Šárka, Eliška Václavíková, Vlasta Sýkorová, et al.. (2006). New Multiple Somatic Mutations in the RET Proto-oncogene Associated with a Sporadic Medullary Thyroid Carcinoma. Thyroid. 16(3). 311–316. 18 indexed citations
19.
Dvořáková, Šárka, et al.. (2005). A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. Journal of Pediatric Surgery. 40(6). e1–e6. 13 indexed citations
20.
Dvořáková, Šárka, Eliška Václavíková, J Dušková, et al.. (2005). Exon 5 of the RET proto-oncogene: A newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg. Journal of Endocrinological Investigation. 28(1). 905–909. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliška Václavíková Breakdown of academic impact, for papers by Vlasta Sýkorová Breakdown of academic impact, for papers by Agnieszka Walczyk Breakdown of academic impact, for papers by Zbigniew Wygoda Breakdown of academic impact, for papers by Claire Coire Breakdown of academic impact, for papers by Margarida M. Moura Breakdown of academic impact, for papers by Naisi Huang Breakdown of academic impact, for papers by Ana Clode Breakdown of academic impact, for papers by Fernando Rodrigues Breakdown of academic impact, for papers by Alyaksandr V. Nikitski
Rankless by CCL
2026